Abstract
The main strategy in surgical treatment of Crohn’s disease is resection of the diseased segment, despite possible development of postoperative nutritional impairment and lowered quality of life (QOL) caused by short bowel syndrome and early postoperative relapse. To overcome postoperative short bowel syndrome, minimal resection is highly recommended, and furthermore strictureplasty is now used in many institutions. Many reports have shown that strictureplasty is safe, has a low rate of surgical complications, and displays identical surgical results as intestinal resection. To apply this procedure to various types of Crohn’s disease, different derivatives of this procedure, such as Heineke–Mikulicz, Finney, Jaboulay, and double Heineke–Mikulicz type, as well as side-to-side isoperistaltic strictureplasty have evolved. In performing strictureplasty, the severity of stenosis is more important than the length of the stricture, because a simple but long stricture can be easily managed by any method of this procedure. Further, it is necessary to investigate the surgical specimens via histopathological analysis of frozen section when neoplastic change is suspected. Now, functional end-to-end anastomosis using a linear stapler has become the most frequently used method in intestinal surgery. Many studies have documented less leakage, morbidity, and anastomotic recurrence as well as shorter hospital stay following stapled anastomosis. As part of the postoperative maintenance treatment regimen, various drugs, such as masalamine, immunomodulators, and infliximab, have been shown to demonstrate positive efficacy when used solely or in combination. Endoscopic examination should be done regularly, and the maintenance treatment regimen should be adjusted according to the disease activity.
Similar content being viewed by others
References
Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002;8:244–50.
Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn’s disease. Gastroenterology. 1993;105:1716–23.
Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut. 2005;54:237–41.
Lee ECG, Papaioannou N. Minimal Surgery for chronic obstruction in patients with extensive or universal Crohn’s disease. Ann R Coll Surg Engl. 1982;64:229–33.
Dehn TCB, Kettlewell MGW, Mortensen NJM, Lee ECG, Jewell DP. Ten-year experience of strictureplasty for obstructive Crohn’s disease. Br J Surg. 1989;76:339–41.
Sayfan J, Wilson DAL, Allan A, Andrew H, Alexander-Williams J. Recurrence after strictureplasty or resection for Crohn’s disease. Br J Surg. 1989;76:335–8.
Sharif H, Alexander-Williams J. The role of strictureplasty in Crohn’s disease. Int Surg. 1992;77:15–8.
Hurst RD, Michelassi F. Strictureplasty for Crohn’s disease: techniques and long-term results. World J Surg. 1998;22:359–63.
Fazio VW, Galandiuk S, Jagelman DG, Lavery IC. Strictureplasty in Crohn’s disease. Ann Surg. 1989;210:621–5.
Fazio VW, Tjandra JJ. Strictureplasty for Crohn’s disease with multiple long stricture. Dis Colon Rectum. 1993;36:71–2.
Sasaki I, Funayama Y, Naito H, Fukushima K, Shibata C, Matsuno S. Extended strictureplasty for multiple skipped strictures of Crohn’s disease. Dis Colon Rectum. 1996;39:342–4.
Michelassi F. Side-to-side isoperistaltic strictureplasty for multiple Crohn’s strictures. Dis Colon Rectum. 1996;39:345–9.
Stebbing JF, Jewell DP, Kettlewell MGW, Mortensen NJM. Long-term results of recurrence and reoperation after strictureplasty for obstructive Crohn’s disease. Br J Surg. 1995;82:1471–4.
Ozuner G, Fazio VW, Lavery IC, Milsom JW, Strong S. Reoperative rates for Crohn’s disease following strictureplasty. Long-term analysis. Dis Colon Rectum. 1996;39:1199–203.
Fearnhead NS, Chowdhury R, Box B, George BD, Jewell DP. Mortensen NJM: long-term follow-up of strictureplasty for Crohn’s disease. Br J Surg. 2006;93:475–82.
Michelassi F, Hurst RD, Melis M, Rubin M, Cohen R, Gasparitis A, et al. Side-to-side isoperistaltic strictureplasty in extensive Crohn’s disease: a prospective longitudinal study. Ann Surg. 2000;232:401–8.
Funayama Y, Fukushima K, Shibata C, Takahashi K, Ogawa H, Sasaki I. Current status and results of strictureplasy for obstructive Crohn’s disease (in Japanese). J Jpn Soc Coloproctol. 2005;58:891–6.
Marchetti F, Fazio VW, Ozuner G. Adenocarcinoma arising from a strictureplasty site in Crohn’s disease. Report of a case. Dis Colon Rectum. 1996;39:1315–21.
Jaskowiak NT, Michelassi F. Adenocarcinoma at a strictureplasty site in Crohn’s disease. Report of a case. Dis Colon Rectum. 2001;44:284–6.
Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL. Coremans G: natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25:665–72.
Moskovitz D, McLeod RS, Greenberg GR, Cohen Z. Operative and environmental risk factors for recurrence of Crohn’s disease. Int J Colorectal Dis. 1999;14:224–6.
Tersigni R, Alessandroni L, Barreca M, Piovanello P, Prantera C. Does stapled functional end-to-end anastomosis affect recurrence of Crohn’s disease after ileocolonic resection? Hapatogastroenterology. 2003;50:1422–5.
Simillis C, Purkayastha S, Yamamoto T, Strong S, Tekkis PP. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn’s disease. Dis Colon Rectum. 2007;50:1674–87.
Yamamoto T, Bain IM, Mylonakis E, Allan RN, Keighley MRB. Stapled functional end-to-end anastomosis versus sutured end-to-end anastomosis after ileocolonic resection in Crohn’s disease. Scand J Gastroenterol. 1999;34:708–13.
Ikeuchi H, Kusunoki M, Yamamura T. Long-term results of stapled and hand-sewn anastomosis in patients with Crohn’s disease. Dig Surg. 2000;17:493–6.
Munoz-Juarez M, Yamamoto T, Wolff BG, Keighley MRB. Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn’s disease. Dis Colon Rectum. 2001;44:20–6.
Hashemi M, Novell JR, Lewis AAM. Side-to-side stapled anastomosis may delay recurrence in Crohn’s disease. Dis Colon Rectum. 1998;41:1293–6.
Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H. European cooperative Crohn’s disease study (ECCDS): results of drug treatment. Gastroenterology. 1984;86:249–66.
Rutgeerts P, Hiele M, Geboes K, Peeters M, Penninckx F, Aerts R, et al. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology. 1995;108:1617–21.
D’Haens G, Vermeire S, Van Assche G, Noman M, Aerden I, Van Olmen G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease: a controlled randomized trial. Gastroenterology. 2008;135:1123–9.
McLeod RS, Wolff BG, Steinhart AH, Carryer PW, O’Rourke K, Andrew DF, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn’s disease. Gastroenterology. 1995;109:404–13.
Camma C, Guinta M, Rosselli M, Cottone M. Mesalamine in the maintenance treatment of Crohn’s disease: a meta-analysis adjusted for confounding variables. Gastroenterology. 1997;113:1465–73.
Lochs H, Mayers M, Fleig WE, Mortensen PB, Bauer P, Genser D, et al. Prophylaxis of postoperative relapse in Crohn’s disease with mesalamine: European cooperative Crohn’s disease study VI. Gastroenterology. 2000;118:264–73.
Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, Cohen RD, et al. Post-operative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: a two year trial. Gastroenterology. 2004;127:723–9.
Ardizzone S, Maconi G, Sampierto GM, Russo A, Radice E, Colombo E, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease. Gastroenterology. 2004;127:730–40.
Takagi S, Utsunomiya K, Kuriyama S, Yokoyama H, Takahashi S, Iwabuchi M, et al. Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn’s disease; a randomized-controlled trial. Aliment Pharmacol Ther. 2006;24:1333–40.
Regueiro M, Schrout W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, et al. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology. 2009;136:441–50.
Blum E, Katz JA. Postoperative therapy for Crohn’s disease. Inflamm Bowel Dis. 2009;15:463–72.
Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99:956–63.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Funayama, Y., Takahashi, Ki. & Sasaki, I. Surgical management in intestinal Crohn’s disease. Clin J Gastroenterol 3, 1–5 (2010). https://doi.org/10.1007/s12328-009-0129-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-009-0129-1